The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhagwandas Kalidas Patel
Arunjyoti Bio Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2025 ,inter alia, to consider and approve Bonus Issue
Anka India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/03/2025 ,inter alia, to consider and approve 1. Approve the proposal for issuance of one or more instruments including equity shares/convertible securities either by way of Preferential Issue/Rights Issue/or any other mode as may be considered or as may be deemed fit and/or other modalities including determination of price thereon. 2. To increase the Authorized Share Capital of the Company and consequent amendments in Memorandum of Association of the Company, if any; 3. To change in the main object clause of the Company and consequent amendments in Memorandum of Association of the Company, if any; 4. To seek members' approval wherever applicable by means of passing the requisite resolution(s) for the above-said board decisions and other matters connected therewith and/or incidental thereto; and 5. Any other item with the permission of the chair.
Enclosed herewith Disclosure under Regulation 30 of SEBI(LODR) Regulations, 2015 relating to Appointment of Mr.Vishvajit Dilipsinh Jadeja as Chief Finacial Officer (CFO)
